![Yohan Hazot](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yohan Hazot
No más puestos en curso
Perfil
Yohan Hazot worked as the Chief Technology Officer at VYNE Pharmaceuticals Ltd.
from 2014 to 2017.
He graduated from the Institut National des Sciences Appliquées de Strasbourg.
Antiguos cargos conocidos de Yohan Hazot.
Empresas | Cargo | Fin |
---|---|---|
VYNE Pharmaceuticals Ltd.
![]() VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Director Técnico/Científico/I+D | 01/08/2017 |
Formación de Yohan Hazot.
Institut National des Sciences Appliquées de Strasbourg | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
VYNE Pharmaceuticals Ltd.
![]() VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Yohan Hazot